Complete metabolic remission in an 84-year old patient with relapsed/refractory diffuse large B-cell lymphoma following combination immunotherapy with lenalidomide plus rituximab

Int J Hematol. 2020 Oct;112(4):597-598. doi: 10.1007/s12185-020-02989-5. Epub 2020 Sep 4.

Ciprian Tomuleasa^{1

2}, Sabina Iluta^{3

4}, Sergiu Pasca³, Andrei Roman^{5

6}, Doina Piciu^{5

6}, Ciprian Jitaru³, Patric Teodorescu^{3

4}, Ioana Rus^{3

4}, Anca Bojan^{3

4}, Delia Dima³, Mihnea Zdrenghea^{3

4}, Bobe Petrushev⁷

¹ Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania. ciprian.tomuleasa@umfcluj.ro.
² Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Gheorghe Marinescu Street, 400124, Cluj-Napoca, Romania. ciprian.tomuleasa@umfcluj.ro.
³ Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania.
⁴ Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Gheorghe Marinescu Street, 400124, Cluj-Napoca, Romania.
⁵ Department of Radiology, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj-Napoca, Romania.
⁶ Department of Radiology,, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania.
⁷ Medfuture Research Center, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj-Napoca, Romania.

No abstract available

Publication types